PE-295 Pioglitazone Remains Effective to Prevent Development of New Coronary Lesion in Diabetics at Medium Term : Results from Multicenter CHAMPION Trial(PE050,Diabetes 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)